Metabolon Reaches Diabetes Research Deals in Mexico | GenomeWeb

NEW YORK (GenomeWeb News) – Metabolon today announced research collaborations and a licensing agreement aimed at diabetes in Mexico and Latin America.

As part of the multiyear, royalty-based research collaborations, Metabolon's Quantose IR technology will be used in several diabetes prevention studies in Mexico. The licensing deal with Patia Biopharma provides exclusive access in Mexico to Metabolon's prediabetes technology for evaluating insulin resistance in Mexico through Patia and Clinica Ruiz's laboratory network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.